Latest filing published 24 Mar 2021 for Turning Point Therapeutics, Inc., €22k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Brian Lee Baker: trading record in brief
All filings by Brian Lee Baker on record concern Turning Point Therapeutics, Inc. Over a trading history stretching from 22 April 2019 to 23 March 2021, the count stands at 24 filings.
On the open market, the record shows 1 purchase worth €45k and 12 sales worth €5.5M. The net balance comes to €5.4M on the selling side. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 3 share grants and 8 option exercises. In 2021 alone, the filings show no purchases and 12 sales.
The newest entry dates from 24 March 2021: an option exercise of €22k, in Turning Point Therapeutics, Inc. The most recent open-market purchase was published on 24 April 2019, 2,756 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Brian Lee Baker
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 11,904 shares@ US$2.190.4% of flowCommon StockSEC:0001209191-21-022949:1
- 1,298 shares@ US$3.200.1% of flowCommon StockSEC:0001209191-21-022949:2
- 4,545 shares@ US$5.120.3% of flowCommon StockSEC:0001209191-21-022949:3
- 10,688 shares@ US$7.431.2% of flowCommon StockSEC:0001209191-21-022949:4
- 4,919 shares@ US$97.897.0% of flowCommon StockSEC:0001209191-21-022949:5
- 4,459 shares@ US$98.766.4% of flowCommon StockSEC:0001209191-21-022949:6
- 1,996 shares@ US$100.072.9% of flowCommon StockSEC:0001209191-21-022949:7
- 5,010 shares@ US$100.987.4% of flowCommon StockSEC:0001209191-21-022949:8
- 8,061 shares@ US$102.2312.0% of flowCommon StockSEC:0001209191-21-022949:9
- 3,890 shares@ US$102.845.8% of flowCommon StockSEC:0001209191-21-022949:10
- 100 shares@ US$104.170.2% of flowCommon StockSEC:0001209191-21-022949:11
- 1,625 shares0Common StockSEC:0001209191-21-022949:0
- 1,483 shares0Common StockSEC:0001209191-21-009360:0
- 11,905 shares@ US$2.190.4% of flowCommon StockSEC:0001209191-21-002840:0
- 1,299 shares@ US$3.200.1% of flowCommon StockSEC:0001209191-21-002840:1
- 4,545 shares@ US$5.120.3% of flowCommon StockSEC:0001209191-21-002840:2
- 10,689 shares@ US$7.431.1% of flowCommon StockSEC:0001209191-21-002840:3
- 2,800 shares@ US$122.654.8% of flowCommon StockSEC:0001209191-21-002840:4
- 900 shares@ US$120.161.5% of flowCommon StockSEC:0001209191-21-002840:5
- 5,200 shares@ US$121.578.9% of flowCommon StockSEC:0001209191-21-002840:6
- 21,825 shares@ US$122.4437.6% of flowCommon StockSEC:0001209191-21-002840:7
- 513 shares@ US$123.020.9% of flowCommon StockSEC:0001209191-21-002840:8
- 216 shares@ US$31.1312.0% of flowCommon StockSEC:0001209191-20-002502:0
- 2,800 shares@ US$18.0088.0% of flowCommon StockSEC:0001209191-19-025787:0Canonical exit: 21 Jul 2019 (T+90)
24 of 24 declarations
